From Symptoms to Solutions: Unlocking the Prognostic Potential of the Atellica IM High-Sensitivity Troponin I Assay

Wednesday, July 30
10:15 - 11:15 a.m.
Exhibit Hall Theater #1
Supported by Siemens Healthineers

Overview

From early detection in the ED to long-term care planning, discover how high-sensitivity troponin I (hs-cTnI) is helping to shape the future of cardiac care. This panel brings together voices from cardiology and laboratory science to explore how insights from hs-cTnI results may be applied in real-world settings to inform clinical decisions, support interdisciplinary collaboration, and improve patient outcomes.

Moderator

Amy K. Saenger, PhD, DABCC
Director of Evidence Generation, Global Medical Affairs, Siemens Healthineers

Speakers

Alan H.B. Wu, PhD, DABCC, FACB
Professor, Lab Medicine, Core Lab Co-Director, Zuckerberg San Francisco General Hospital; University of California San Francisco

Lori B. Daniels, MD, MAS, FACC, FAHA
Professor of Medicine; Director, Cardiovascular Intensive Care Unit, Division of Cardiovascular Medicine; University of California San Diego

Explore the full ADLM 2025 Scientific Program Online

Browse by day, topic, type, and more to discover the latest in lab medicine in ADLM 2025 Plenaries, Scientific Sessions, Roundtables, University Courses, and special events.

Claim ACCENT & CME Credit

ADLM 2025 attendees that are eligible to claim credits, must do so by October 31. 

Advertisement
Advertisement